The purinergic system as a mechanism for platelet activation in hit

被引：0
|
作者：
Jeske, WP [1 ]
Zaman, S [1 ]
Chau, S [1 ]
Messmore, HL [1 ]
Bakhos, M [1 ]
Walenga, JM [1 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
497
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [1] Platelet pre-activation is not a primary mechanism for platelet activation in HIT.
    Jeske, W
    Zaman, S
    Messmore, HL
    Walenga, JM
    BLOOD, 1998, 92 (10) : 86B - 86B
  • [2] Inhibition of HIT serum/heparin-induced platelet activation by purinergic receptor antagonists.
    Jeske, WP
    Patel, A
    Chau, S
    Shetty, A
    Walenga, JM
    BLOOD, 2000, 96 (11) : 49B - 49B
  • [3] Exploration of Purinergic Signaling Pathways As a Mechanism of Platelet Activation in Antiphospholipid Syndrome
    Jacintho, Bruna Cardoso
    Leonardi, Guilherme
    Mazetto, Bruna
    Oliveira, Jose
    Monica, Fabiola Zakia
    De Paula, Erich Vinicius
    Orsi, Fernanda A.
    BLOOD, 2024, 144 : 2610 - 2611
  • [4] Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation
    Chen, Yu
    Yao, Yongli
    Sumi, Yuka
    Li, Andrew
    To, Uyen Kim
    Elkhal, Abdallah
    Inoue, Yoshiaki
    Woehrle, Tobias
    Zhang, Qin
    Hauser, Carl
    Junger, Wolfgang G.
    SCIENCE SIGNALING, 2010, 3 (125) : ra45
  • [5] In vitro effect of an antithrombin in platelet activation by HIT antibodies
    P Eichler
    N Lubenow
    R Raschke
    A Greinacher
    Critical Care, 9 (Suppl 1):
  • [6] Platelet activation and thrombosis by antibodies against VEGF and CD40 ligand: Extending the mechanism of HIT
    Amirkhosravi, Ali
    Meyer, Todd
    Langer, Florian
    Robson, Theresa
    Robles, Liza
    Desai, Hina
    Davila, Monica
    Amaya, Mildred
    Francis, John L.
    CIRCULATION, 2007, 116 (16) : 75 - 75
  • [7] MOLECULAR MECHANISM OF PLATELET ACTIVATION
    SIESS, W
    FORTSCHRITTE DER MEDIZIN, 1985, 103 (40) : 937 - 937
  • [8] Inhibition of platelet activation in HIT: Thrombin inhibitors versus anti-platelet agents
    Jeske, WP
    Szatkowski, E
    Wood, JJ
    Messmore, HL
    Haas, S
    Bakhos, M
    Herbert, JM
    Walenga, JM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 261 - 262
  • [9] Platelet purinergic receptors
    Kunapuli, SP
    Dorsam, RT
    Kim, S
    Quinton, TM
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) : 175 - 180
  • [10] Platelet purinergic receptors
    Oury, C
    Hoylaerts, MF
    THROMBOSIS: FUNDAMENTAL AND CLINICAL ASPECTS, 2003, : 93 - 118
12345